Clinical experience with cefoxitin sodium in immunologically compromised patients. 1978

J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
July 1978, The Journal of antimicrobial chemotherapy,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
July 1978, The Journal of antimicrobial chemotherapy,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
July 1978, The Journal of antimicrobial chemotherapy,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
July 1978, The Journal of antimicrobial chemotherapy,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
July 1978, The Journal of antimicrobial chemotherapy,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
July 1978, The Journal of antimicrobial chemotherapy,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
January 1984, The Japanese journal of antibiotics,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
January 1982, Minerva urologica,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
May 2013, BJU international,
J Christodoulopoulos, and A Katrahoura, and E Housianakou, and A Karabelis, and B Seitanides
November 1981, Boletin de la Asociacion Medica de Puerto Rico,
Copied contents to your clipboard!